Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Evaluation of antioxidant, anti-inflammatory, anticancer activities and molecular docking of Moringa oleifera seed oil extract against experimental model of Ehrlich ascites carcinoma in Swiss female albino mice

Fig. 1

A and E Normal hepatic lobules, central vein (C), and hepatic cells in the livers of the control group after 1 and 2 weeks of treatment. B and F Normal hepatic lobules, central vein (C), and hepatic cells in the liver of the Moringa seed oil extract (MOE) group after 1 and 2 weeks of treatment. C and G Severe congestion of hepatic blood vessels, diffuse vacuolar degeneration (arrow), and necrotic nuclei of hepatic cells (N) in the Ehrlich ascites carcinoma (EAC) group after 1 and 2 weeks of treatment. D and H Normal hepatic lobules, central vein (C), and hepatic cells in the liver of the EAC group treated with MOE after 1 and 2 weeks of treatment (H&E, × 400)

Back to article page